VIRIDIAN CAPITAL
VIRIDIAN CAPITAL is a Seed, Series A, Series B and Series C+ fund in the US investing in cannabis, psychedelics and cbd.
- Stages
- Seed, Series A, Series B, Series C+
- Sectors
- cannabis, psychedelics, cbd
- Invests in
- US-wide
- Actively investing
- Yes
- Founded
- 2014
- Website
- viridianca.com
Check size not disclosed
Thesis
Viridian Capital Advisors, founded in 2014 and based in New York City, is a corporate finance, M&A, advisory, and research firm with a primary focus on the legal cannabis, CBD, and psychedelics industries. Their strategy involves representing companies, investors, lenders, buyers, and sellers within these niche sectors. Viridian utilizes its proprietary "Viridian Deal Tracker," which has analyzed over $60 billion in deals since January 2015, to provide market intelligence for capital allocation. While not managing traditional VC/PE funds, they have closed over $250 million in financing and approximately $400 million in M&A transactions. They serve as advisors and facilitators for companies seeking capital or M&A, and for investors in these emerging markets. They have advised on deals such as THC Design and 365 Holdings.
Common questions
Does VIRIDIAN CAPITAL invest at the Seed stage?
Yes. VIRIDIAN CAPITAL lists Seed, Series A, Series B and Series C+ among the stages it invests in.
Where does VIRIDIAN CAPITAL invest?
VIRIDIAN CAPITAL invests in the US.